Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Levine

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Diseases of the Colon and Rectum|November 13, 2004
Pilot study of the quality initiative in rectal cancer strategyMarko I Simunovic, Craig A Paterson, Angela J Coates, et al.
Cancer Treatment Reviews|September 18, 2002
What is the role for antithrombotics in cancer care? Interactive session with panel discussionAjay K Kakkar, Mark N Levine, Paolo Prandoni, et al.
BMC Surgery|February 19, 2008
The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgeryMarko Simunovic, Charles Goldsmith, Lehana Thabane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5Mark N Levine, Kathleen I Pritchard, Vivien H C Bramwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
The importance of reporting patient recruitment details in phase III trialsJames R Wright, Sarah Bouma, Ian Dayes, et al.
Journal of Bone Oncology|November 19, 2015
Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-studyChristina L Addison, Gregory R Pond, Brandy Cochrane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancerAgnes Y Y Lee, Mark N Levine, Gregory Butler, et al.
Journal of Cancer Survivorship : Research and Practice|April 22, 2015
A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trialAnnelies H Boekhout, Elizabeth Maunsell, Gregory R Pond, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the ProstateIan S Dayes, Sameer Parpia, Jaclyn Gilbert, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|August 15, 2009
Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survivalMarko Simunovic, Eddy Rempel, Marc-Erick Thériault, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Diseases of the Colon and Rectum|November 13, 2004
Pilot study of the quality initiative in rectal cancer strategyMarko I Simunovic, Craig A Paterson, Angela J Coates, et al.
Cancer Treatment Reviews|September 18, 2002
What is the role for antithrombotics in cancer care? Interactive session with panel discussionAjay K Kakkar, Mark N Levine, Paolo Prandoni, et al.
BMC Surgery|February 19, 2008
The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgeryMarko Simunovic, Charles Goldsmith, Lehana Thabane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5Mark N Levine, Kathleen I Pritchard, Vivien H C Bramwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
The importance of reporting patient recruitment details in phase III trialsJames R Wright, Sarah Bouma, Ian Dayes, et al.
Journal of Bone Oncology|November 19, 2015
Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-studyChristina L Addison, Gregory R Pond, Brandy Cochrane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancerAgnes Y Y Lee, Mark N Levine, Gregory Butler, et al.
Journal of Cancer Survivorship : Research and Practice|April 22, 2015
A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trialAnnelies H Boekhout, Elizabeth Maunsell, Gregory R Pond, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the ProstateIan S Dayes, Sameer Parpia, Jaclyn Gilbert, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|August 15, 2009
Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survivalMarko Simunovic, Eddy Rempel, Marc-Erick Thériault, et al.
Pageof 12